Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > Sell half while you can

<< Previous

Bullboard Posts

Next >>

Comment by dinglehopperon Jan 24, 2021 1:54pm

139 Views

Post# 32371178

RE:Sell half while you can

Maybe if it was only on the CSE but it it's not. They are on the Nasdaq now and I'm sure those Warrants will be in the money soon. This hasen't even started yet, I can't see the people that held through the Nasdaq uplist take even more of a hit than this. Undervalued here to say the least ! With a small float this will blast on good news .

<< Previous

Bullboard Posts

Next >>

Cameco raises uranium output as Q3 results surge